Vertex Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Vertex Pharmaceuticals, Inc. (VRTX)

454.68 -5.91 (-1.28%) USD | NASDAQ | Jan 13, 16:00

453.01 -1.67 (-0.37%) After-Hours: 18:02

View Other Long Term Liabilities (Quarterly) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Amgen, Inc.	Upgrade
Eli Lilly & Co.	Upgrade
Merck & Co., Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade